Your browser doesn't support javascript.
loading
Pathway-centric integrative analysis identifies RRM2 as a prognostic marker in breast cancer associated with poor survival and tamoxifen resistance.
Putluri, Nagireddy; Maity, Suman; Kommagani, Ramakrishna; Kommangani, Ramakrishna; Creighton, Chad J; Putluri, Vasanta; Chen, Fengju; Nanda, Sarmishta; Bhowmik, Salil Kumar; Terunuma, Atsushi; Dorsey, Tiffany; Nardone, Agostina; Fu, Xiaoyong; Shaw, Chad; Sarkar, Tapasree Roy; Schiff, Rachel; Lydon, John P; O'Malley, Bert W; Ambs, Stefan; Das, Gokul M; Michailidis, George; Sreekumar, Arun.
Afiliación
  • Putluri N; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.
  • Maity S; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.
  • Kommagani R; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA.
  • Kommangani R; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA.
  • Creighton CJ; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Putluri V; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.
  • Chen F; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Nanda S; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
  • Bhowmik SK; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA.
  • Terunuma A; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dorsey T; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Nardone A; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
  • Fu X; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA.
  • Shaw C; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Sarkar TR; Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Schiff R; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Hous
  • Lydon JP; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA.
  • O'Malley BW; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Ambs S; Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Das GM; Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Michailidis G; Department of Statistics, University of Michigan, Ann Arbor, MI, USA. Electronic address: gmichail@umich.edu.
  • Sreekumar A; Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA; Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX, USA; Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA; Dan L Duncan Cancer Center, Bay
Neoplasia ; 16(5): 390-402, 2014 May.
Article en En | MEDLINE | ID: mdl-25016594
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ribonucleósido Difosfato Reductasa / Neoplasias de la Mama / Biomarcadores de Tumor / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ribonucleósido Difosfato Reductasa / Neoplasias de la Mama / Biomarcadores de Tumor / Resistencia a Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos